NASDAQ:OTIC
Delisted

Otonomy Stock Signals

etoro logo Buy OTIC
*Your capital is at risk
$0.0085
+0 (+0%)
At Close: Jul 11, 2023

Latest Data & Signals Issued

Below are some of the latest signals issued for Otonomy

General

Signal Type Signal Value Data
Score 0.000 61 days ( 0 %
Last Price $0.0085 0 %
Performance History
7 Days
$0.0085 $0.0085
0%
30 Days
$0.0085 $0.0085
0%
12 Mos
$2.20 $0.0085
-99.61%

4/18

Active Buy Signals

Specific Signals

Short Term
Net score: 20.95
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0085 - $0.0085
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Jul 10, 2023 - 2 days
RSI Short Pivot Signal Buy Very Low Apr 27, 2023 - 51 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 22.83
Signal Type Signal Value Importance Data
Trend - 12 mos -40.39 % Very High Width: 186.84 %
Pred. range - 12 mos N/A - $0.795 High -100.00 % - 9,254.80 %
Short MA 12 mos Sell Very High Apr 10, 2023 - 64 days
Long MA 12 mos Sell Very High Apr 10, 2023 - 64 days
Short/Long MA 12 mos Sell Very High Apr 10, 2023 - 64 days
Pivot Long Buy Low Apr 11, 2023 - 63 days
RSI Long Pivot Signal Buy Low May 08, 2023 - 44 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT OTONOMY
Otonomy
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurotrophic factor that is in Phase IIa clinical trials for the repair of cochlear synaptopathy and the trea...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
SAP
$172.39
7.18% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE